LEP and hepatocellular carcinoma: Albeit not clear whether this increased ER-β expression is unique to leptin treatment or is related to cell proliferation, such induction of ER-β expression in HepG2 cells may potentially play protective roles in leptin-induced HCC development in the presence of E2 or ER-β agonist.